Simple exploration of 131052-47-6

131052-47-6 (3,5-Dimethylisoxazol-4-yl)methanamine 11018874, aIsoxazoles compound, is more and more widely used in various fields.

131052-47-6, (3,5-Dimethylisoxazol-4-yl)methanamine is a Isoxazoles compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,131052-47-6

To a solution of [4-(3 ,4-dihydro- 1 H-isoquinoline-2-sulfonyl)-phenyl] -carbamic acid phenyl ester (370 mg, 0.9 mmoL), C-(3,5-dimethyl-isoxazol-4-yl)-methylamine (115 mg, 0.9 mmoL) and Et3N (0.3 mL, 2.1 mmoL) in MeCN (12 mL) at room temperature and stirred for lh at 80C. The reaction mixture was concentrated to dryness in vacuum and part of the residue (260 mg) was purified by Prep-HPLC to give 1- [4-(3 ,4-dihydro- 1 H-isoquinoline-2-sulfonyl)-phenyl] -3 -(3,5- dimethyl-isoxazol-4-ylmethyl)-urea (41 mg, yield: 10%) as a white solid. ?H NIVIR (300 IVIHz, DMSO-d6): oe = 8.95 (s, 1H), 7.68 (d, J= 8.7 Hz, 2H), 7.59 (d, J= 9.0 Hz, 2H), 7.15-7.11 (m, 4H), 6.67(t,J= 5.7Hz, 1H), 4.13 (s, 2H), 4.05 (d,J= 5.1 Hz, 2H), 3.23 (t,J 5.7 Hz, 2H), 2.84 (t,J4.8 Hz, 2H), 2.37 (s, 3H), 2.20 (s, 3H). MS: m/z 441.0 (M+H).

131052-47-6 (3,5-Dimethylisoxazol-4-yl)methanamine 11018874, aIsoxazoles compound, is more and more widely used in various fields.

Reference£º
Patent; SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE; GARDELL, Stephen; PINKERTON, Anthony B.; SERGIENKO, Eduard; SESSIONS, Hampton; (428 pag.)WO2018/132372; (2018); A1;,
Isoxazole – Wikipedia
Isoxazole | C3H3NO – PubChem

Analyzing the synthesis route of 131052-47-6

131052-47-6, The synthetic route of 131052-47-6 has been constantly updated, and we look forward to future research findings.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.131052-47-6,(3,5-Dimethylisoxazol-4-yl)methanamine,as a common compound, the synthetic route is as follows.

A mixture of (3,5-dimethylisoxazol-4-yl)methanamine (70 mg, 0.6 mmol), 4- phenoxycarbonylamino-benzoic acid ethyl ester (150 mg, 0.5 mmol) and TEA (0.2 mL, 1.6 mmol) in MeCN (8 mL) was stirred at 80 C for 1 h and then concentrated. The residue was diluted with DCM (40 mL), washed with aq.HC1 (1 N, 20 mL) and Sat.NaHCO3 (20 mL). The DCM solution was dried over Na2SO4, concentrated and purified by Prep-HPLC (NH3.H20) to give ethyl 4-(3-((3,5- dimethylisoxazol-4-yl)methyl)ureido)benzoate (50 mg, yield: 30%) as a white solid. ?H NIVIR (400 IVIHz, DMSO-d6): oe = 8.85 (s, 1H), 7.82 (d, J= 8.8 Hz, 2H), 7.50 (d, J 8.8 Hz, 2H), 6.64 (t, J 5.6 Hz, 1H), 4.26 (q, J= 7.2 Hz, 2H), 4.06 (d, J= 5.6 Hz, 2H), 2.38 (s, 3H), 2.21 (s, 3H), 1.29 (t, J 7.2 Hz, 3H). MS: m/z 318.0 (M+H).

131052-47-6, The synthetic route of 131052-47-6 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE; GARDELL, Stephen; PINKERTON, Anthony B.; SERGIENKO, Eduard; SESSIONS, Hampton; (428 pag.)WO2018/132372; (2018); A1;,
Isoxazole – Wikipedia
Isoxazole | C3H3NO – PubChem